Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05552027 · ClinicalTrials.gov registry record · Phase 2
Minnesota HealthSolutions Cellular Car Seat Study
A Phase 2 study, sponsored by Minnesota HealthSolutions.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
NCT05552027: Completed Phase 2 study, sponsored by Minnesota HealthSolutions.
NCT05552027 is a Phase 2 study that has completed, run by Minnesota HealthSolutions. The registered enrollment target is 92 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (31% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05552027, a Phase 2 study, has completed, sponsored by Minnesota HealthSolutions.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate an innovative child safety seat user engagement system (CCS system) designed to actively educate, instruct, and alarm caregivers with information associated with automatically-sensed safety seat misuses/errors via a smartphone application.
Primary Outcome
For each misuse scenario participants will be asked to correct the error in the seat installation or the harness tension. Convertible seats will be used for this phase. For each scenario, we will use a huggable images test doll (age and weight of the doll will be indicated to participants). Study team will record seat direction (forward vs rear facing), harness tension (newtons), insecure attachment of the seat to the vehicle (yes/no).
Interventions
- DEVICE CCS System- Prototype
- DEVICE CCS System- Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2022-11-17 |
| Phase | Phase 2 |
What the finished NCT05552027 record still lists
NCT05552027 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (31% lower).
The record links to 0 conditions, and to 2 interventions - of which CCS System- Prototype is the first listed.
NCT05552027 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05552027 about?
NCT05552027 is a clinical study titled "Minnesota HealthSolutions Cellular Car Seat Study". The objective of the study is to evaluate an innovative child safety seat user engagement system (CCS system) designed to actively educate, instruct, and alarm caregivers with information associated with automatically-sensed safety seat misuses/errors via a smartphone application.
What is the current status of trial NCT05552027?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2022-06-15. Estimated completion is 2022-11-17.
What interventions are being tested in trial NCT05552027?
The interventions under investigation include: CCS System- Prototype (DEVICE), CCS System- Control (DEVICE).
Who is sponsoring clinical trial NCT05552027?
This trial is sponsored by Minnesota HealthSolutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05552027's enrollment target sits among peer trials
92 767th of 2000 higher than 1,230 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI